Company: MBIO
Filing Date: 2025-01-15
Form Type: S-1
Source: 0001410578-25-000028
Chunk: 282

Company: MUSTANG BIO, INC.
Filing Date: 2025-01-15
Form: S-1
Chunk 282
---
 and (iii) extend the original expiration date of the Existing Warrants by five yearsfollowing the receipt of such Warrant Stockholder Approval. The Warrant Amendment Agreement became effective on May 2, 2024. June 2024 Registered Direct Offering and Concurrent Private Placement of Warrants (the “June 2024 Offering”) On June 19, 2024, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with an institutional investor (the “June 2024 Investor”), pursuant to which the Companyagreed to issue and sell, in a registered direct offering priced at-the-market under the rules of Nasdaq (the “Registered Direct Offering”), (i) 3,025,000shares of common stock, at a price per Share of $ 0.41and (ii) pre-funded warrants (the “Pre-Funded Warrants”) to purchase up to 3,105,000shares of our common stock, at a price per Pre-Funded Warrant equal to $ 0.4099, the price per share of common stock, less $ 0.0001. The Pre-Funded Warrants were sold in lieu of shares of common stock to theJune 2024 Investor . The Pre-Funded Warrants have an exercise price of $ 0.0001 per share, became exercisable upon issuance and remain exercisable until exercised in full. The Registered Direct Offering closed on June 21, 2024. The Company intends to use the net proceeds of approximately $ 2.1 million from the Registered Direct Offering for general corporate purposes and working capital requirements. In a concurrent private placement, pursuant to the terms of the Purchase Agreement, the Company also agreed to issue and sell to the June 2024 Investor unregistered warrants (the “Private Placement Warrants”) to purchase up to 6,130,000shares of common stock, at an offering price of $ 0.41per Private Placement Warrant to purchase oneshare of common stock (the “Private Placement” and, together with the Registered Direct Offering, the “Offerings”) (which offering price was included in the purchase price per share of common stock or Pre-Funded Warrant). The Private Placement Warrants have an exercise price of $ 0.41per share (subject to customary adjustments as set forth in the Private Placement Warrants), were exercisable upon issuance and will expire five yearsfrom the date of issuance. The Private Placement Warrants contain customary anti-dilution adjustments to the